Back to search
Adjunctive Treatment of Major Depressive Disorder (MDD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adjunctive Treatment of Major Depressive Disorder (MDD) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adjunctive Treatment of Major Depressive Disorder (MDD) trials you may qualify forThe purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with placebo as an a…
* The goal of this clinical trial is to explore if the treatment with ketamine tablets in addition to standard antidepressant therapy can reduce depressive symp…
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depressio…
This study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder
This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying the return of…
The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepressant (selec…
The study is a Phase 2, double-blind, randomized, placebo-controlled study in Major Depressive Disorder (MDD) participants with an inadequate response to standa…
Demonstrate ability of SEP-363856 to be superior to placebo as an adjunctive therapy to ADT in change from baseline in depressive symptoms (MADRS \& CGI-S) in M…